Navigation Links
Effort aims to spike breast cancer with new approach
Date:3/11/2010

SCOTTSDALE, Ariz. March 11, 2010 Many women live with breast cancer that does not respond to standard medical treatment, a condition that researchers at the Virginia G. Piper Cancer Center at Scottsdale Healthcare want to change by aggressively targeting specific genes.

Improving quality of life and potentially keeping the cancer under control for a longer period of time are goals of a new clinical trial at the cancer center's TGen Clinical Research Services, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).

The pilot study is supported by the Side-Out Foundation, a group founded by volleyball enthusiasts to help wage war on breast cancer.

Women or men with advanced breast cancer that has progressed through three prior treatments are eligible for the trial, available in the western U.S. only at Scottsdale Healthcare's Virginia G. Piper Cancer Center.

"Many are living with refractory, or advanced, breast cancer that has not responded or continues to grow despite standard treatments," explains Nurse Practitioner Gayle Jameson, principal investigator. "What we are offering here is a whole new approach for treating patients with refractory breast cancer."

Biopsied tissue will be analyzed for unique characteristics and abnormal genes in cancer cells, which are then targeted for treatment with FDA-approved anticancer medications. "We may discover that a tumor has a gene mutation that responds to a drug not typically used in a 'one-size-fits-all' approach," explains Jameson.

"What we are doing here is precisely matching a treatment to a specific type of cancer cell mutation and abnormal protein signaling pathways that may activate cancer cell growth. The patient would then be treated with one or more medications based on the information provided by the analyses."

Researchers call the Side-Out study the "next generation of breast cancer treatment," expanding
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Highmark and its Employees Donate $161,686 for Haiti Disaster Relief Efforts
2. New Alzheimers Prevention Efforts, and Non-Drug Treatments, Featured at 25th Conference of Alzheimers Disease International
3. Having Prediabetes May Not Kick-Start Prevention Efforts
4. California Dental Hygienists Say National Children's Dental Health Month Should Be a Yearlong Effort
5. Buildium Announces Fundraising Campaign to Benefit Haiti Relief Efforts
6. ChildCare Education Institute Supports the First Ladys Efforts to Reduce Childhood Obesity
7. JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts
8. Lighthouse To Help Relief Efforts In Haiti
9. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
10. Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts
11. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Texas (PRWEB) June 03, 2015 ... and Analytics solutions, today announced the launch of ... EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. The ... additional visualization capabilities and advanced functionalities into their ... the DSX suite, Visual BI is adding key ...
(Date:6/3/2015)... panel of independent experts has spent weeks considering the ... awards presented tonight at TU-Automotive Detroit 2015. , Naturally, ... can now be revealed as: , Car Maker of ... aside by taking the coveted Car Maker of the ... of expert judges., Stand out comments included: , ...
(Date:6/3/2015)... 2015 Researchers at the University of ... and say the tried-and-true marker mesothelin is the best ... on the research. Click here to read it ... for Asbestos Related Diseases say, even though a mesothelin ... still preferable to fibulin-3 for identifying mesothelioma. , ...
(Date:6/3/2015)... For the fourth time in less than a ... advertising agency, has been honored by a respected independent organization—this ... has been selected as a Semi-Finalist for the 2015 “Small ... at a luncheon sponsored by Adcock Financial Group and Simpson ... , “This luncheon will include important information about the next ...
(Date:6/3/2015)... June 03, 2015 Sitting at a ... discomfort in the back, neck, shoulders and/or wrists. This ... injuries. In addition, recent research links sitting for long ... chronic diseases. Fortunately, three inventors from Oakville, Ontario, are ... a desk. , They have developed a prototype for ...
Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2
... proteins in drug-resistant strains of the Staphylococcus aureus ... blood cellsa key process ensuring that S. aureus ... at the National Institute of Allergy and Infectious ... Health. , S. aureus disease is a global ...
... means intervention may be more effective, researchers say , , ... early rheumatoid arthritis could be identified and enrolled in ... new type of assessment and excluded two traditional assessments, ... looked at 292 people, average age 54, seen at ...
... 6 Month Period, Nasacort AQ Did Not Cause ... Suppression in This Same Age Group, BRIDGEWATER, N.J., ... Allergy, Asthma & Immunology (ACAAI) annual meeting,suggests that the ... used safely and effectively to treat children,aged 2-5 years ...
... Four members of the same,family, who owned ... Equipment,(DME) companies and Comprehensive Outpatient Rehabilitation Facilities have,each ... Medicare fraud, Assistant,Attorney General Alice S. Fisher of ... of the Southern District of Florida announced today., ...
... CHATSWORTH, Calif., Nov. 9 Innovation Management Group,Inc. ... The Magnifier 1.50, a,low cost, full screen magnification ... designed for individuals who have extreme visual,impairments or ... a few hundred to,several thousand dollars. The Magnifier ...
... if used wisely and in the right patients, experts say ... of almost $5 billion to be paid out to those ... the drug,s maker, Merck & Co., may have hoped to ... , But, according to experts, the move has merely swung ...
Cached Medicine News:Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6Health News:Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud 2Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 3Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 4
(Date:6/3/2015)... 02, 2015 Research and Markets  ( http://www.researchandmarkets.com/research/dg23tb/global ... Pharmaceutical Packaging Market 2015-2019" report to their offering. ... at a CAGR of 5.9% over the period 2014-2019. ... market is the rise in demand for vials and ... second highest growth among all the segments at a ...
(Date:6/3/2015)... VIEW, Calif. , June 3, 2015 /PRNewswire/ ... healthcare sector around the globe and keeping track ... in this competitive market. In particular, ensuring user-friendliness, ... detection sensitivity are the most important factors influencing ... their consumer base. New analysis from ...
(Date:6/3/2015)... , June 3, 2015 ... "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic ... Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons ... MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular Devices ... by 2019 with a CAGR of 7.4% from ...
Breaking Medicine Technology:Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4
... to Announce First Quarter Fiscal 2011 Financial Results -- HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
... Board: ANTXE ) today announced that it had ... to the effect that its Common Stock would be removed ... 2010. The letter indicated that FINRA took ... under the Exchange Act three times in the past two ...
Cached Medicine Technology:China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 2China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 3China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 4China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 5China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 6China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results 7AcuNetx Announces Change in Trading Status 2
... The AutoPulse Resuscitation System consists of ... compression assembly and a rechargeable battery pack ... LifeBand is designed for adults with weight ... of 29.9 to 51.2 inches (76 to ...
... single information technology platform, the VERICIS ... from different sites (office, clinic, hospital) ... x-ray angiography, echo, nuclear, MR, hemodynamics, ... digital record on the cardiac patient. ...
... a pocket sized bidirectional Doppler, designed for use ... and extra long cable (6 feet) are detachable ... placed outside of the sterile field, to maintain ... Doppler's features include red and green LED's in ...
... The CVS4 Complete Vascular System combines cutting edge ... a computerized peripheral vascular package available in the ... format which allows you to do vascular examinations ... to, while storing patient waveforms and data in ...
Medicine Products: